European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
Increasing Incidence of Thrombosis, Paralleled by Maturing Life cycles of Existing Products, Underpin the Demand for Novel Alternatives
03-Feb-2012 -
The increasing incidence of thrombosis, paralleled by the maturing life cycles of existing products, are motivating the need for novel alternatives. Establishing end-user confidence and ensuring cost-effectiveness pose significant challenges to market advancement. However, the launch of three ...
anticoagulants
Frost & Sullivan
generics
+1